{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:50:56Z","timestamp":1791967856760,"version":"4.3.4"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173070"],"award-info":[{"award-number":["82173070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103291"],"award-info":[{"award-number":["82103291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372760"],"award-info":[{"award-number":["82372760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573904"],"award-info":[{"award-number":["82573904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QC277"],"award-info":[{"award-number":["ZR2023QC277"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024MH099"],"award-info":[{"award-number":["ZR2024MH099"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211340"],"award-info":[{"award-number":["tsqn202211340"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tstp20221141"],"award-info":[{"award-number":["tstp20221141"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ebiom.2026.106493","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:34:34Z","timestamp":1790451274000},"page":"106493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumour-associated dsRNA accumulation and innate immune activation: mechanistic basis and therapeutic strategies"],"prefix":"10.1016","volume":"132","author":[{"given":"Shaoping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangwei","family":"Fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7150\/ijbs.103877","article-title":"Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy","volume":"21","author":"Wang","year":"2025","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13059-021-02357-4","article-title":"Endogenous retroviruses in the origins and treatment of cancer","volume":"22","author":"Jansz","year":"2021","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molcel.2023.11.033","article-title":"The competitive landscape of the dsRNA world","volume":"84","author":"Cottrell","year":"2024","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tig.2023.12.002","article-title":"In search of critical dsRNA targets of ADAR1","volume":"40","author":"Levanon","year":"2024","journal-title":"Trends Genet"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.trecan.2025.08.010","article-title":"Viral mimicry in cancer therapy","volume":"11","author":"Rosenberg","year":"2025","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400087","article-title":"Unleashing viral mimicry: a combinatorial strategy to enhance the efficacy of PARP7 inhibitors","volume":"47","author":"Manetsch","year":"2025","journal-title":"Bioessays"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41577-025-01172-3","article-title":"Transposable elements as instructors of the immune system","volume":"25","author":"Schmidleithner","year":"2025","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tig.2025.08.002","article-title":"Unmasked: transposable elements as drivers and targets in cancer","volume":"42","author":"Grinwald","year":"2026","journal-title":"Trends Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13100-025-00383-8","article-title":"Endogenous retroviruses in aging and cancer: from genomic defense to oncogenic activation","volume":"16","author":"Arantes Dos Santos","year":"2025","journal-title":"Mob DNA"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/epigenomes9030033","article-title":"Innate immune surveillance and recognition of epigenetic marks","volume":"9","author":"Wang","year":"2025","journal-title":"Epigenomes"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106493_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2012.11.048","article-title":"Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5","volume":"152","author":"Wu","year":"2013","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106493_bib13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1084\/jem.20080091","article-title":"Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5","volume":"205","author":"Kato","year":"2008","journal-title":"J Exp Med"},{"issue":"7522","key":"10.1016\/j.ebiom.2026.106493_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature13590","article-title":"Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates","volume":"514","author":"Goubau","year":"2014","journal-title":"Nature"},{"issue":"6252","key":"10.1016\/j.ebiom.2026.106493_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.immuni.2015.11.001","article-title":"Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development","volume":"43","author":"Pestal","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40364-025-00739-5","article-title":"Toll-like receptor 3: a double-edged sword","volume":"13","author":"Hsieh","year":"2025","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13437","article-title":"Z-nucleic acid sensing and activation of ZBP1 in cellular physiology and disease pathogenesis","volume":"329","author":"Mishra","year":"2025","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib19","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1042\/BST20230727","article-title":"Suppression of double-stranded RNA sensing in cancer: molecular mechanisms and therapeutic potential","volume":"52","author":"Young","year":"2024","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106493_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.tig.2022.03.013","article-title":"ADAR1 and its implications in cancer development and treatment","volume":"38","author":"Baker","year":"2022","journal-title":"Trends Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymthe.2025.09.041","article-title":"Designing nucleic acid-based therapeutics for cancer treatment: updates on the state of the art","volume":"34","author":"Peng","year":"2026","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib22","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41588-025-02430-9","article-title":"ADAR1 editing is necessary for only a small subset of cytosolic dsRNAs to evade MDA5-mediated autoimmunity","volume":"57","author":"Sun","year":"2025","journal-title":"Nat Genet"},{"issue":"46","key":"10.1016\/j.ebiom.2026.106493_bib23","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102134118","article-title":"Introns encode dsRNAs undetected by RIG-I\/MDA5\/interferons and sensed via RNase L","volume":"118","author":"Chitrakar","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7836","key":"10.1016\/j.ebiom.2026.106493_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-020-2844-1","article-title":"Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency","volume":"588","author":"Mehdipour","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2017.12.016","article-title":"Breaching self-tolerance to alu duplex RNA underlies MDA5-mediated inflammation","volume":"172","author":"Ahmad","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib27","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1158\/2159-8290.CD-21-0506","article-title":"Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137569","article-title":"DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer","volume":"5","author":"de Cubas","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1122160","article-title":"Unraveling the molecular pathways of DNA-Methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors","volume":"5","author":"Strick","year":"2016","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s42003-025-08413-0","article-title":"Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes","volume":"8","author":"Patel","year":"2025","journal-title":"Commun Biol"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012357","article-title":"High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy","volume":"13","author":"Nacev","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ebiom.2026.106493_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmorc.2026.100129","article-title":"ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival","volume":"5","author":"Demanelis","year":"2026","journal-title":"ESMO Rare Cancers"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1158\/0008-5472.CAN-24-4419","article-title":"Dynamic and ongoing De Novo L1 retrotransposition contributes to genome plasticity and intrapatient heterogeneity in ovarian cancer","volume":"86","author":"Pradhan","year":"2026","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib35","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/1878-0261.70067","article-title":"Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer","volume":"19","author":"Glossner","year":"2025","journal-title":"Mol Oncol"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106493_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016289118","article-title":"Noncanonical immune response to the inhibition of DNA methylation by Staufen1 via stabilization of endogenous retrovirus RNAs","volume":"118","author":"Ku","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib37","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.immuni.2024.10.015","article-title":"Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms","volume":"57","author":"Sun","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib38","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1038\/s41467-024-51363-0","article-title":"Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells","volume":"15","author":"Lopez-Polo","year":"2024","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib39","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/s12276-023-01121-x","article-title":"Mitochondrial nucleic acids in innate immunity and beyond","volume":"55","author":"Yoon","year":"2023","journal-title":"Exp Mol Med"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib40","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202402764","article-title":"Mitochondrial double-stranded RNA homeostasis depends on cell-cycle progression","volume":"7","author":"Xavier","year":"2024","journal-title":"Life Sci Alliance"},{"issue":"21","key":"10.1016\/j.ebiom.2026.106493_bib41","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1182\/bloodadvances.2023012077","article-title":"Mitochondrial dsRNA from B-all cells stimulates mesenchymal stromal cells to become cancer-associated fibroblasts","volume":"8","author":"Burt","year":"2024","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106493_bib42","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41422-024-00978-5","article-title":"ANT2 functions as a translocon for mitochondrial cross-membrane translocation of RNAs","volume":"34","author":"Wang","year":"2024","journal-title":"Cell Res"},{"key":"10.1016\/j.ebiom.2026.106493_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.779739","article-title":"Hypoxia regulates endogenous double-stranded RNA production via reduced mitochondrial DNA transcription","volume":"11","author":"Arnaiz","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.molcel.2024.11.025","article-title":"RNA sensing induced by chromosome missegregation augments anti-tumor immunity","volume":"85","author":"Sasaki","year":"2025","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100725","article-title":"PP039 inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma","volume":"7","author":"Chan","year":"2022","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105742","article-title":"Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing","volume":"300","author":"Iwata","year":"2024","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/2159-8290.CD-24-0094","article-title":"Chronic viral mimicry induction following p53 loss promotes immune evasion","volume":"15","author":"Ishak","year":"2025","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/2159-8290.CD-25-0104","article-title":"Loss of p53 induces tolerance to viral mimicry as a mechanism of immune evasion in early tumorigenesis","volume":"15","author":"Murayama","year":"2025","journal-title":"Cancer Discov"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106493_bib49","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-19-2306","article-title":"Hypoxia induces transcriptional and translational downregulation of the type I IFN pathway in multiple cancer cell types","volume":"80","author":"Miar","year":"2020","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib50","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1101\/gr.280820.125","article-title":"A transcriptome-wide systematic search does not detect A-to-I RNA editing in cis-antisense RNA duplexes","volume":"36","author":"Rosenwasser","year":"2026","journal-title":"Genome Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202152984","article-title":"TERT activates endogenous retroviruses to promote an immunosuppressive tumour microenvironment","volume":"23","author":"Mao","year":"2022","journal-title":"EMBO Rep"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106493_bib52","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41576-025-00830-5","article-title":"Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease","volume":"26","author":"Li","year":"2025","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tcb.2024.06.006","article-title":"ADAR1: from basic mechanisms to inhibitors","volume":"35","author":"Rehwinkel","year":"2025","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-cellbio-101323-020352","article-title":"ADAR1: beyond just an RNA editor","volume":"41","author":"Maronek","year":"2025","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/procel\/pwae039","article-title":"Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets","volume":"16","author":"Cheng","year":"2025","journal-title":"Protein Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib56","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1016\/j.ymthe.2025.05.021","article-title":"Targeting RNA adenosine editing and modification enzymes for RNA therapeutics","volume":"33","author":"Vlachogiannis","year":"2025","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib57","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-editing enzyme ADAR1 controls innate immune responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021757118","article-title":"Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms","volume":"118","author":"Sun","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib59","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1093\/nar\/gkad265","article-title":"The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms","volume":"51","author":"Kleinova","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib60","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1261\/rna.079509.122","article-title":"Generation of a new Adar1p150 (-\/-) mouse demonstrates isoform-specific roles in embryonic development and adult homeostasis","volume":"29","author":"Liang","year":"2023","journal-title":"RNA"},{"issue":"21","key":"10.1016\/j.ebiom.2026.106493_bib61","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.molcel.2023.09.018","article-title":"ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation","volume":"83","author":"Hu","year":"2023","journal-title":"Mol Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009516","article-title":"RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain","volume":"17","author":"Kim","year":"2021","journal-title":"PLoS Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib63","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201833","article-title":"ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses","volume":"218","author":"Herzner","year":"2021","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13059-020-1937-3","article-title":"Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity","volume":"21","author":"Barak","year":"2020","journal-title":"Genome Biol"},{"issue":"7923","key":"10.1016\/j.ebiom.2026.106493_bib65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41586-022-05052-x","article-title":"RNA editing underlies genetic risk of common inflammatory diseases","volume":"608","author":"Li","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib66","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1038\/s41467-025-58412-2","article-title":"Cooperative role of PACT and ADAR1 in preventing aberrant PKR activation by self-derived double-stranded RNA","volume":"16","author":"Manjunath","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109500","article-title":"ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation","volume":"36","author":"de Reuver","year":"2021","journal-title":"Cell Rep"},{"issue":"7920","key":"10.1016\/j.ebiom.2026.106493_bib68","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"issue":"7920","key":"10.1016\/j.ebiom.2026.106493_bib69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-04896-7","article-title":"ADAR1 mutation causes ZBP1-dependent immunopathology","volume":"607","author":"Hubbard","year":"2022","journal-title":"Nature"},{"issue":"7920","key":"10.1016\/j.ebiom.2026.106493_bib70","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-022-04878-9","article-title":"ADAR1 averts fatal type I interferon induction by ZBP1","volume":"607","author":"Jiao","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib71","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1038\/s41467-025-62309-5","article-title":"Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1\/2-mutant cancers","volume":"16","author":"Chabanon","year":"2025","journal-title":"Nat Commun"},{"issue":"7914","key":"10.1016\/j.ebiom.2026.106493_bib72","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106493_bib73","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.molcel.2025.02.017","article-title":"Biochemical profiling and structural basis of ADAR1-mediated RNA editing","volume":"85","author":"Deng","year":"2025","journal-title":"Mol Cell"},{"key":"10.1016\/j.ebiom.2026.106493_bib74","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cancergen.2024.10.007","article-title":"Identification and characterization of ADAR1 mutations and changes in gene expression in human cancers","volume":"288\u2013289","author":"Valentine","year":"2024","journal-title":"Cancer Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113704","article-title":"Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing","volume":"43","author":"Rivera","year":"2024","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib76","article-title":"Over-expression of ADAR1 in mice does not initiate or accelerate cancer formation in vivo","volume":"5","author":"Mendez Ruiz","year":"2023","journal-title":"NAR Cancer"},{"issue":"101","key":"10.1016\/j.ebiom.2026.106493_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk0412","article-title":"GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing","volume":"9","author":"Heraud-Farlow","year":"2024","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108976","article-title":"TDP-43 prevents endogenous RNAs from triggering a lethal RIG-I-dependent interferon response","volume":"35","author":"Dunker","year":"2021","journal-title":"Cell Rep"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106493_bib79","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103922","article-title":"Prevention of dsRNA-induced interferon signaling by AGO1x is linked to breast cancer cell proliferation","volume":"39","author":"Ghosh","year":"2020","journal-title":"EMBO J"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106493_bib80","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/0008-5472.CAN-20-3790","article-title":"Targeting DDX3X triggers antitumor immunity via a dsRNA-Mediated tumor-intrinsic type I interferon response","volume":"81","author":"Choi","year":"2021","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106493_bib81","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1158\/0008-5472.CAN-21-1677","article-title":"MYC- and MIZ1-dependent vesicular transport of double-strand RNA controls immune evasion in pancreatic ductal adenocarcinoma","volume":"81","author":"Krenz","year":"2021","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib82","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2159-8290.CD-23-0486","article-title":"Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer","volume":"14","author":"Murayama","year":"2024","journal-title":"Cancer Discov"},{"issue":"100","key":"10.1016\/j.ebiom.2026.106493_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado8758","article-title":"Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry","volume":"9","author":"Zhou","year":"2024","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13426","article-title":"Established and emerging roles of DEAD\/H-box helicases in regulating infection and immunity","volume":"329","author":"Parthun","year":"2025","journal-title":"Immunol Rev"},{"issue":"793","key":"10.1016\/j.ebiom.2026.106493_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado4370","article-title":"The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts","volume":"17","author":"Wang","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2026.106493_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101198","article-title":"DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC","volume":"67","author":"Zhang","year":"2025","journal-title":"Neoplasia"},{"key":"10.1016\/j.ebiom.2026.106493_bib87","article-title":"RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib88","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1038\/s41467-025-60293-4","article-title":"Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC\/CDK2\/DNMT1 pathway","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"issue":"110","key":"10.1016\/j.ebiom.2026.106493_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adq2055","article-title":"A noncanonical cytoplasmic role for BUB1 in restraining DNA damage-induced dsRNA accumulation and sensing within stress granules","volume":"10","author":"Hu","year":"2025","journal-title":"Sci Immunol"},{"issue":"8071","key":"10.1016\/j.ebiom.2026.106493_bib90","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-025-09104-w","article-title":"Ku limits RNA-induced innate immunity to allow alu expansion in primates","volume":"643","author":"Zhu","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113684","article-title":"Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer","volume":"43","author":"Hosseini","year":"2024","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113783","article-title":"XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells","volume":"43","author":"Zou","year":"2024","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106493_bib93","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cas.13551","article-title":"Roles of protein kinase R in cancer: potential as a therapeutic target","volume":"109","author":"Watanabe","year":"2018","journal-title":"Cancer Sci"},{"issue":"6857","key":"10.1016\/j.ebiom.2026.106493_bib94","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106493_bib95","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1073\/pnas.1519657113","article-title":"Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6176","key":"10.1016\/j.ebiom.2026.106493_bib96","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1249845","article-title":"Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response","volume":"343","author":"Han","year":"2014","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.ebiom.2026.106493_bib97","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.molcel.2025.09.008","article-title":"The RIG-I-like receptor family of immune proteins","volume":"85","author":"van Huizen","year":"2025","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib98","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1093\/nar\/gkv389","article-title":"Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling","volume":"43","author":"Ibsen","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib99","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1074\/jbc.M114.601625","article-title":"Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells","volume":"290","author":"Palchetti","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2026.106493_bib100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fimmu.2019.00503","article-title":"TLR3 activation of intratumoral CD103(+) dendritic cells modifies the tumor infiltrate conferring anti-tumor immunity","volume":"10","author":"Roselli","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib101","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/0008-5472.CAN-10-3490","article-title":"TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer","volume":"71","author":"Salaun","year":"2011","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib102","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/cdd.2012.22","article-title":"dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8","volume":"19","author":"Estornes","year":"2012","journal-title":"Cell Death Differ"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib103","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-018-0850-0","article-title":"Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis","volume":"9","author":"Alkurdi","year":"2018","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.5","article-title":"Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells","volume":"4","author":"Bernardo","year":"2013","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12885-023-10721-9","article-title":"High expression of TLR3 in triple-negative breast cancer predicts better prognosis-data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib106","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1673126","article-title":"Toll-like receptor 3 -926T>A increased the risk of breast cancer through decreased transcriptional activity","volume":"8","author":"Fan","year":"2019","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/intimm\/dxae061","article-title":"Intra-tumoral delivery of 5'ppp-dsRNA induces a robust antitumor response via RIG-I activation and Bcl-2 gene downregulation in a murine model of prostate cancer","volume":"37","author":"Ganguly","year":"2024","journal-title":"Int Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib108","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1073\/pnas.1815071116","article-title":"OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug","volume":"116","author":"Banerjee","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"61","key":"10.1016\/j.ebiom.2026.106493_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2550","article-title":"OAS1\/RNase L executes RIG-I ligand-dependent tumor cell apoptosis","volume":"6","author":"Boehmer","year":"2021","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106493_bib110","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/eji.201242902","article-title":"Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-beta production capable of improving dendritic cell function","volume":"43","author":"Gatti","year":"2013","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007624","article-title":"Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity","volume":"11","author":"Bhoopathi","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib112","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ymthe.2018.11.012","article-title":"Nanoparticle delivery of RIG-I agonist enables effective and safe adjuvant therapy in pancreatic cancer","volume":"27","author":"Das","year":"2019","journal-title":"Mol Ther"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106493_bib113","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1158\/0008-5472.CAN-17-3985","article-title":"Helicase-driven activation of NFkappaB-COX2 pathway mediates the immunosuppressive component of dsRNA-driven inflammation in the human tumor microenvironment","volume":"78","author":"Theodoraki","year":"2018","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106493_bib114","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1158\/0008-5472.CAN-20-2324","article-title":"RIG-I-Like receptor LGP2 is required for tumor control by radiotherapy","volume":"80","author":"Zheng","year":"2020","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib115","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1038\/s41467-025-58433-x","article-title":"PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration","volume":"16","author":"Ahmad","year":"2025","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib116","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41419-024-07175-7","article-title":"Sensing of endogenous retroviruses-derived RNA by ZBP1 triggers PANoptosis in DNA damage and contributes to toxic side effects of chemotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis"},{"issue":"25","key":"10.1016\/j.ebiom.2026.106493_bib117","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","article-title":"IRE1alpha silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer","volume":"187","author":"Xu","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib118","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2537547123","article-title":"Viral mimicry may help explain immunogenic cell death","volume":"123","author":"Levine","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib119","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2026.106493_bib120","article-title":"ISG20 stimulates anti-tumor immunity via a double-stranded RNA-induced interferon response in ovarian cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib121","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-021-02853-y","article-title":"Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway","volume":"19","author":"Long","year":"2021","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106493_bib122","article-title":"Hiltonol, a dsRNA mimic, promotes NK cell anticancer cytotoxicity through TAZ cytoplasmic sequestration","volume":"6","author":"Wong","year":"2023","journal-title":"Adv Ther (Weinh)"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib123","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/2159-8290.CD-25-0587","article-title":"Priming with DNMT inhibitors potentiates PD-1 immunotherapy by triggering viral mimicry in Relapsed\/refractory NK\/T-cell lymphoma","volume":"15","author":"Huang","year":"2025","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2026.106493_bib124","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2025.05.007","article-title":"Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response","volume":"281","author":"Zhang","year":"2025","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib126","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41422-019-0224-x","article-title":"Sustained type I interferon signaling as a mechanism of resistance to PD-1 blockade","volume":"29","author":"Jacquelot","year":"2019","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib127","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1038\/s41467-023-38252-8","article-title":"Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib128","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.1502638","article-title":"Chronic type I IFN is sufficient to promote immunosuppression through accumulation of myeloid-derived suppressor cells","volume":"198","author":"Taleb","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41419-021-04487-w","article-title":"The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106493_bib130","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib131","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/2159-8290.CD-19-1416","article-title":"Inactivation of Fbxw7 impairs dsRNA sensing and confers resistance to PD-1 blockade","volume":"10","author":"Gstalder","year":"2020","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib132","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-25-3231","article-title":"ARID1A mediates SWI\/SNF-independent maintenance of heterochromatin architecture to restrain viral mimicry and immunogenicity in Colon cancer","volume":"86","author":"Li","year":"2026","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib133","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41467-026-69456-3","article-title":"Triple targeting of STING, TGF-\u03b2, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response","volume":"17","author":"Yi","year":"2026","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib134","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/cas.15241","article-title":"PolyI:C attenuates transforming growth factor-\u03b2 signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer","volume":"113","author":"Tamura","year":"2022","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib135","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/1878-0261.12890","article-title":"Anti-pyroptotic function of TGF-\u03b2 is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells","volume":"15","author":"Tamura","year":"2021","journal-title":"Mol Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib136","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/0008-5472.CAN-11-3850","article-title":"Therapeutic efficacy of bifunctional siRNA combining TGF-\u03b21 silencing with RIG-I activation in pancreatic cancer","volume":"73","author":"Ellermeier","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib137","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41568-023-00653-8","article-title":"Towards targeting transposable elements for cancer therapy","volume":"24","author":"Liang","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib138","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011650","article-title":"EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response","volume":"13","author":"Zhu","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib139","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41401-025-01639-y","article-title":"DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I\/MDA5-MAVS to enhance antitumor immunity","volume":"47","author":"Tu","year":"2026","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004974","article-title":"Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer","volume":"10","author":"Gomez","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"7737","key":"10.1016\/j.ebiom.2026.106493_bib141","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106493_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218071","article-title":"Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I\/MDA5-MAVS pathway","volume":"635","author":"Jia","year":"2025","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib143","article-title":"Inhibiting ADAR1-mediated excessive epigenetic A-to-I RNA editing improves the immune microenvironment and increases sensitivity to immunotherapy in lung adenocarcinoma","volume":"7","author":"Wang","year":"2026","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.ebiom.2026.106493_bib144","article-title":"Depletion of the RNA-editing enzyme ADAR1 invigorates the antitumor immunity of NK cells","volume":"13","author":"Chen","year":"2026","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib145","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause aicardi-gouti\u00e8res syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib146","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1038\/s41467-026-71207-3","article-title":"A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR","volume":"17","author":"Yi","year":"2026","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114615","article-title":"Identification of ADAR1i-124: the first effective A-to-I RNA editing inhibitor with promising cancer therapeutic potential","volume":"29","author":"Minakuchi","year":"2026","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib148","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12935-026-04202-9","article-title":"8-Chloro-adenosine inhibits breast cancer progression by inducing ferroptosis via the ADAR1\/miR-101-3p\/SLC7A11 axis","volume":"26","author":"Hao","year":"2026","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ebiom.2026.106493_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113801","article-title":"Virus-mimicking nanoparticle potentiates in-situ cancer vaccines by reversing intratumoral DCs via stimulating cytosolic nucleic acid sensors","volume":"383","author":"Chu","year":"2025","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202306892","article-title":"Lipid nanoparticle encapsulation empowers Poly(I:C) to activate cytoplasmic RLRs and thereby increases its adjuvanticity","volume":"20","author":"Lamoot","year":"2024","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.b.35487","article-title":"Cationic polystyrene latex nanocarriers for immunostimulatory long double-stranded RNA delivery to ovarian cancer cells","volume":"112","author":"Aldor","year":"2024","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106493_bib152","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1002\/smll.201401353","article-title":"An iron oxide nanocarrier for dsRNA to target lymph nodes and strongly activate cells of the immune system","volume":"10","author":"Cobaleda-Siles","year":"2014","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106493_bib153","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/chem.201504629","article-title":"Targeting innate immunity with dsRNA-Conjugated mesoporous silica nanoparticles promotes antitumor effects on breast cancer cells","volume":"22","author":"Ultimo","year":"2016","journal-title":"Chemistry"},{"issue":"565","key":"10.1016\/j.ebiom.2026.106493_bib154","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0391","article-title":"Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors","volume":"12","author":"M\u00e1rquez-Rodas","year":"2020","journal-title":"Sci Transl Med"},{"issue":"25","key":"10.1016\/j.ebiom.2026.106493_bib155","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1200\/JCO-24-02595","article-title":"BO-112 plus pembrolizumab for patients with Anti-PD-1-resistant advanced melanoma: phase II clinical trial SPOTLIGHT-203","volume":"43","author":"M\u00e1rquez-Rodas","year":"2025","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106493_bib156","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1158\/2159-8290.CD-25-1132","article-title":"Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft-tissue sarcoma: preclinical and phase I results","volume":"16","author":"Deng","year":"2026","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib157","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes","volume":"13","author":"Dri","year":"2023","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202503771","article-title":"Engineered immunoagonist non-coding RNA (incRNA) activates dual TLR pathways for cancer immunotherapy","volume":"15","author":"Forster","year":"2026","journal-title":"Adv Healthc Mater"},{"issue":"36","key":"10.1016\/j.ebiom.2026.106493_bib159","article-title":"RIG-I-Inducing small molecules potently inhibit HMA-resistant AML through igniting the overloaded dsRNA arsenal","volume":"12","author":"Chen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106493_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116233","article-title":"Pseudouridine synthase 1-targeted therapy activates antiviral immunity to boost cancer immunotherapy","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109068","article-title":"Targeted delivery of immune-stimulating bispecific RNA, inducing apoptosis and anti-tumor immunity in cancer cells","volume":"27","author":"Rady","year":"2024","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib162","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1039\/C8BM01064A","article-title":"Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy","volume":"7","author":"Jacobson","year":"2019","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ebiom.2026.106493_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.837610","article-title":"A cell-based screen identifies HDAC inhibitors as activators of RIG-I signaling","volume":"9","author":"Fraile-Bethencourt","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106493_bib164","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002953","article-title":"Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy","volume":"9","author":"Alvarez","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"45","key":"10.1016\/j.ebiom.2026.106493_bib165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409559121","article-title":"Reprogramming tumor microenvironment via systemic delivery of TLR3 agonist and manganese nanoparticle","volume":"122","author":"Cho","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib166","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41467-025-67414-z","article-title":"Structural basis of double-stranded RNA recognition by the J2 monoclonal antibody","volume":"17","author":"Bou-Nader","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib167","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1101\/gr.203992.116","article-title":"Identification of the long, edited dsRNAome of LPS-stimulated immune cells","volume":"26","author":"Blango","year":"2016","journal-title":"Genome Res"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106493_bib168","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.molcel.2018.07.029","article-title":"PKR senses nuclear and mitochondrial signals by interacting with endogenous double-stranded RNAs","volume":"71","author":"Kim","year":"2018","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106493_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002317","article-title":"Identification of widespread ultra-edited human RNAs","volume":"7","author":"Carmi","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ebiom.2026.106493_bib170","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/ncomms5726","article-title":"A genome-wide map of hyper-edited RNA reveals numerous new sites","volume":"5","author":"Porath","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib171","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13059-023-03012-w","article-title":"L-GIREMI uncovers RNA editing sites in long-read RNA-seq","volume":"24","author":"Liu","year":"2023","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106493_bib172","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41592-024-02298-3","article-title":"Systematic assessment of long-read RNA-seq methods for transcript identification and quantification","volume":"21","author":"Pardo-Palacios","year":"2024","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106493_bib173","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cell.2019.05.027","article-title":"Atlas of subcellular RNA localization revealed by APEX-seq","volume":"178","author":"Fazal","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2026.106493_bib174","article-title":"Single-cell RNA editing identifies T cell ADAR1 as a key regulator of immune exhaustion and Anti-PD-1 resistance in colorectal cancer","author":"Kang","year":"2026","journal-title":"Adv Sci"},{"issue":"25","key":"10.1016\/j.ebiom.2026.106493_bib175","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","article-title":"Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer","volume":"187","author":"You","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106493_bib176","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.stem.2023.01.008","article-title":"Reversal of malignant ADAR1 splice isoform switching with rebecsinib","volume":"30","author":"Crews","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106493_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100879","article-title":"Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: modulating the cold tumor microenvironment","volume":"6","author":"Nair","year":"2025","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106493_bib178","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1038\/s41467-024-48073-y","article-title":"TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II trial","volume":"15","author":"Everson","year":"2024","journal-title":"Nat Commun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:20:00Z","timestamp":1791966000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426003774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":178,"alternative-id":["S2352396426003774"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106493","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour-associated dsRNA accumulation and innate immune activation: mechanistic basis and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106493"}}